-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-07-15
Values as of: 2019-07-15
The investment seeks to provide long-term total return. The fund will seek to achieve its investment objective by allocating assets across several different investment strategies, including traditional and alternative investment strategies, such as those utilized by certain hedge funds. The strategies identified by the adviser for the fund fall into the following broad categories: Equity Long/Short, Event Driven and Global Macro Based strategies. The fund will invest its assets based on a systematic investment process for securities selection and asset allocation.
Currency: USD
Country : USA
Inception Date: 12/09/2016
Primary Benchmark: ICE BofAML US 3M Trsy Bill TR USD
Primary Index: Morningstar Mod Tgt Risk TR USD
Gross Expense Ratio: NA%
Management Expense Ratio: 0.79 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| EPRSQ | EPIRUS Biopharmaceuticals Inc | 0.01 % |
| PLXS | Plexus Corp | 0.01 % |
| AAT | American Assets Trust Inc | 0.01 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| SOJE | SOJE | 0.00 % |
-0.42 (-2.11%) |
USD 65.72B |
| JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
-0.31 (-0.55%) |
USD 32.43B |
| DTB | DTB | 0.00 % |
-0.23 (-1.13%) |
USD 26.58B |
| DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
-0.14 (-0.46%) |
USD 26.00B |
| GBTC | Grayscale Bitcoin Trust (BTC) | 0.00 % |
+0.70 (+1.23%) |
USD 23.75B |
| JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
+0.02 (+0.04%) |
USD 22.73B |
| SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.05 (+0.05%) |
USD 19.79B |
| AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
-0.35 (-0.39%) |
USD 10.49B |
| DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
-0.18 (-0.46%) |
USD 10.15B |
| DFAT | Dimensional U.S. Targeted Valu.. | 0.00 % |
-0.31 (-0.60%) |
USD 9.40B |
N/A
| Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 2.42% | 17% | F | 21% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | F | ||
| Total Return | 2.42% | 16% | F | 20% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -2.31% | 37% | F | 45% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | F | ||
| Total Return | -2.31% | 30% | F | 38% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | F | ||
| Total Return | N/A | N/A | N/A | N/A | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -1.76% | 40% | F | 34% | F | ||
| Dividend Return | -1.76% | 20% | F | 29% | F | ||
| Total Return | 0.00% | 20% | F | N/A | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 2.89% | 100% | F | 97% | N/A | ||
| Risk Adjusted Return | -60.83% | 20% | F | 11% | F | ||
| Market Capitalization | 0.15B | 55% | F | 27% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
